Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2012
03/22/2012US20120071506 Methods for treating cns disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles
03/22/2012US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071503 Positive allosteric modulators of group ii mglurs
03/22/2012US20120071502 Novel phenoxyisobutyric acid compounds and methods for synthesis
03/22/2012US20120071495 Treatment for Neurological and Mental Disorders
03/22/2012US20120071494 Pyrazolopyridine kinase inhibitors
03/22/2012US20120071493 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
03/22/2012US20120071487 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
03/22/2012US20120071486 Thienopyrimidine compounds and use thereof
03/22/2012US20120071483 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
03/22/2012US20120071481 Isoxazole-5-carboxamide derivatives
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071471 Novel benzoxazinone derivatives useful for the treatment of cns disorders
03/22/2012US20120071470 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
03/22/2012US20120071469 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
03/22/2012US20120071468 Methods of treating mild cognitive impairment (mci) and related disorders
03/22/2012US20120071467 Amide derivative
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012US20120071464 Method of treatment of obsessive compulsive disorder with ondansetron
03/22/2012US20120071462 Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
03/22/2012US20120071461 Substituted Benzamide Compounds
03/22/2012US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists
03/22/2012US20120071459 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/22/2012US20120071453 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071446 Dosage regimen of an s1p receptor agonist
03/22/2012US20120071433 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives
03/22/2012US20120071432 Central administration of stable formulations of therapeutic agents for cns conditions
03/22/2012US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis
03/22/2012US20120071423 Heterotricyclic AMPA Receptor Antagonists for Treatment of Epilepsy, Pain, and Other Neurological Disorders and Diseases
03/22/2012US20120071416 Low frequency glatiramer acetate therapy
03/22/2012US20120071415 Dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma)
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120070521 Method of extraction from withania somnifera and one or more fractions containing pharmacologically active ingredients obtained therefrom
03/22/2012US20120070520 Composition containing a bean extract for improving blood circulation and increasing vascular health
03/22/2012US20120070519 Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants
03/22/2012US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives
03/22/2012US20120070504 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
03/22/2012US20120070501 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions
03/22/2012US20120070500 Nanoparticles Of Cerium Oxide Targeted To An Amyloid-Beta Antigen Of Alzheimer's Disease And Associated Methods
03/22/2012US20120070496 Antidepressant dosage form
03/22/2012US20120070495 Oral formulations and lipophilic salts of methylnaltrexone
03/22/2012US20120070494 Treatment for Attention-Deficit Hyperactivity Disorder
03/22/2012US20120070445 Brain-derived gonadotropins and cognition
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070436 Antigen-binding proteins
03/22/2012US20120070420 Compositions and methods for treating psychiatric and neurodegenerative disorders
03/22/2012US20120070410 Imidazolothiazole compounds and methods of use thereof
03/22/2012US20120070407 Therapy for Promoting Cell Growth
03/22/2012US20120070403 Use of g-csf for the extension of the therapeutic time-window of thrombolytic stroke therapy
03/22/2012US20120070390 Topical drug delivery system with dual carriers
03/22/2012US20120070385 Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
03/22/2012US20120070379 Immunotherapy regimes dependent on apoe status
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012US20120067361 Plant fiber product and method for its manufacture
03/22/2012DE102010041117A1 Neue substituierte Amino-, Imino-1,2,4 Triazin Derivate New substituted amino, imino-1,2,4 triazine derivatives
03/22/2012CA2811285A1 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
03/22/2012CA2811241A1 Terpenoid analogues and uses thereof for treating neurological conditions
03/22/2012CA2811086A1 Step-derived peptide for brain injury treatment
03/22/2012CA2808246A1 Arylosulfonamides for the treatment of cns diseases
03/21/2012EP2431368A1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
03/21/2012EP2431361A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof
03/21/2012EP2431360A1 Derivatives of dihydrobenzoxathiazepine, method of preparing same and pharmaceutical compositions containing them as well as their uses as modulators of AMPA receptors
03/21/2012EP2431359A1 Process for preparing diaminophenothiazinium compounds
03/21/2012EP2431355A1 New crystalline form vi of agomelatine, preparation method and application thereof
03/21/2012EP2431051A1 Type-1 interferons for the treatment of multiple sclerosis
03/21/2012EP2431042A1 Methods for the treatment of central nervous system injury via a tapered administration protocol
03/21/2012EP2431039A1 Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1A activity
03/21/2012EP2431037A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
03/21/2012EP2431034A1 Adhesive patch-containing package bag and method for storing adhesive patch
03/21/2012EP2430183A1 Antipsychotic treatment based on drd2 or ankk1 snp genotype
03/21/2012EP2430049A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
03/21/2012EP2430038A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
03/21/2012EP2430031A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
03/21/2012EP2430022A1 1,2,3-triazolo ý4,3-a¨pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
03/21/2012EP2430021A1 7-aryl-1,2,4-triazoloý4,3-a¨pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
03/21/2012EP2430012A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2430007A1 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
03/21/2012EP2430003A1 Oligomer-containing substituted aromatic triazine compounds
03/21/2012EP2429998A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2429992A1 Treatment of mci and alzheimer's disease
03/21/2012EP2429573A1 Lactoferrin and brain health and protection in adults
03/21/2012EP2429572A1 Lactoferrin and brain health and development in infants
03/21/2012EP2429565A2 Peptides and aptamers for targeting of neuron or nerves
03/21/2012EP2429537A2 Treatment of stress
03/21/2012EP2429530A2 Methods and compositions for treating degenerative and ischemic disorders
03/21/2012EP2429526A1 Ranolazine for the treatment of cns disorders
03/21/2012EP2429523A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
03/21/2012EP2429522A2 Method of decreasing ubiquitylated protein levels
03/21/2012EP2429521A2 Sublingual dexmedetomidine compositions and methods of use thereof
03/21/2012EP2429518A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
03/21/2012EP2429514A1 Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof
03/21/2012EP2429499A2 Method for impregnation with supercrtitical co2
03/21/2012EP2429296A1 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
03/21/2012EP2151241B1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
03/21/2012EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
03/21/2012EP1910364B1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/21/2012EP1734989B1 Novel use of antisecretory factor
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 1833